High Tower Advisors, LLC Inhibrx, Inc. Transaction History

High Tower Advisors, LLC

  • $64.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$16.96 - $27.82 $13,703 - $22,478
-808 Reduced 0.61%
131,900 $3.42 Million
Q4 2022

Feb 08, 2023
BUY
$20.18 - $33.33 $16,305 - $26,930
808 Added 0.61%
132,708 $3.27 Million
Q3 2022

Nov 09, 2022
BUY
$11.58 - $24.73 $1.41 Million - $3.01 Million
121,900 Added 1219.0%
131,900 $2.37 Million
Q1 2022

May 12, 2022
BUY
$19.89 - $43.18 $198,900 - $431,800
10,000 New
10,000 $223,000

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $617M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email